Trial protocol for a multicenter randomized controlled trial to assess the efficacy and safety of intravenous ketamine for chronic daily headaches: the “KetHead” trial

Overview of attention for article published in Trials, March 2023

Altmetric Badge

Mentioned by

twitter: 2 X users

Readers on

mendeley: 9 Mendeley

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 9,187 followers.

Hoydonckx et al 2023-Trial protocol for a multicenter randomized controlled trial to assess the efficacy and safety of intravenous ketamine for chronic daily headaches: the "KetHead" trial. https://t.co/3GeL76toKD #FOAMed #MedEd #headache #ketamine

03 Mar 2023

Reply Repost Favourite

Trial protocol for a multicenter randomized controlled trial to assess the efficacy and safety of intravenous ketamine for chronic daily headaches: the "KetHead" trial https://t.co/wuLIOoq3za

01 Mar 2023

Reply Repost Favourite

Trial protocol for a multicenter randomized controlled trial to assess the efficacy and safety of intravenous ketamine for chronic daily headaches: the "KetHead" trial https://t.co/qaDI2Zlmb6

01 Mar 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.